CLINICAL TRIALS PROFILE FOR MAKENA PRESERVATIVE FREE
✉ Email this page to a colleague
All Clinical Trials for MAKENA PRESERVATIVE FREE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02937766 ↗ | Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women | Terminated | AMAG Pharmaceuticals, Inc. | Phase 3 | 2016-10-07 | To demonstrate that Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) delivered subcutaneously via auto-injector is associated with less pain as compared to intramuscular injections of Makena® |
NCT02940522 ↗ | Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women | Completed | AMAG Pharmaceuticals, Inc. | Phase 1 | 2016-09-01 | To demonstrate that a single dose of Makena® delivered SQ via auto-injector has comparable bioavailability to a single IM injection of Makena®. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAKENA PRESERVATIVE FREE
Condition Name
Condition Name for MAKENA PRESERVATIVE FREE | |
Intervention | Trials |
Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women | 1 |
Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for MAKENA PRESERVATIVE FREE
Trials by Country
Clinical Trial Progress for MAKENA PRESERVATIVE FREE
Clinical Trial Phase
Clinical Trial Sponsors for MAKENA PRESERVATIVE FREE
Sponsor Name